Laboratory Corporation of America, Burlington, North Carolina.
Specialist Haemostasis Unit, Department of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
Semin Thromb Hemost. 2023 Sep;49(6):571-579. doi: 10.1055/s-0042-1756196. Epub 2022 Sep 2.
Mixing studies have long been in the clinical laboratory armamentarium for investigating unexpected, prolonged activated partial thromboplastin time (aPTT) or prothrombin time (PT). The purpose of the mixing study is to identify whether the aPTT/PT prolongation is secondary to a factor deficiency versus an inhibitor, which would present as a "corrected" and "noncorrected" mixing study, respectively. The differentiation between a factor deficiency and inhibitor may likely further direct clinical decisions, including additional diagnostic testing or factor replacement therapy. While aPTT/PT mixing studies are simple tests to perform, there is a lack of standardization for both the testing protocol and the interpretation of what is considered to be a corrected or noncorrected mixing study result. This review will describe the common indications for the mixing test, preanalytic variables that may affect mixing study performance, and describe several methods for interpreting the results of aPTT and PT mixing tests.
混合研究长期以来一直是临床实验室的有力工具,用于研究意外的、延长的活化部分凝血活酶时间(aPTT)或凝血酶原时间(PT)。混合研究的目的是确定 aPTT/PT 延长是继发于因子缺乏还是抑制剂,分别表现为“纠正”和“未纠正”混合研究。因子缺乏和抑制剂之间的区别可能进一步指导临床决策,包括进一步的诊断测试或因子替代治疗。虽然 aPTT/PT 混合研究是简单的测试,但在测试方案和对被认为是纠正或未纠正混合研究结果的解释方面缺乏标准化。这篇综述将描述混合试验的常见适应证、可能影响混合研究结果的分析前变量,并描述几种解释 aPTT 和 PT 混合试验结果的方法。